Literature DB >> 9105090

Nosocomial acquisition of Burkholderia gladioli in patients with cystic fibrosis.

M L Wilsher1, J Kolbe, A J Morris, D F Welch.   

Abstract

Burkholderia gladioli has been reported as colonizing the airways of patients with cystic fibrosis (CF) but has not previously been associated with adverse outcome. We describe six patients with CF in whom the same strain of B. gladioli, on the basis of ribotyping and biochemical characteristics, was grown in their sputum. Acquisition of this organism was followed by a fatal outcome in all six patients; one had a rapid decline in respiratory status and another developed fulminant B. gladioli bacteremia. Evidence suggests that patient-to-patient transmission of the organism occurred, and supports nosocomial infection in the ward and/or outpatient clinic despite general and stringent infection-control measures. This is the first report of adverse clinical outcome following sputum colonization with B. gladioli, and the first to demonstrate person-to-person transmission.

Entities:  

Mesh:

Year:  1997        PMID: 9105090     DOI: 10.1164/ajrccm.155.4.9105090

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  13 in total

1.  Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex.

Authors:  D A Henry; E Mahenthiralingam; P Vandamme; T Coenye; D P Speert
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

Review 2.  Taxonomy and identification of the Burkholderia cepacia complex.

Authors:  T Coenye; P Vandamme; J R Govan; J J LiPuma
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

Review 3.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

4.  Simple and inexpensive but highly discriminating method for computer-assisted DNA fingerprinting of Pseudomonas aeruginosa.

Authors:  T H Al-Samarrai; N Zhang; I L Lamont; L Martin; J Kolbe; M Wilsher; A J Morris; J Schmid
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

5.  Species-specific PCR as a tool for the identification of Burkholderia gladioli.

Authors:  P W Whitby; L C Pope; K B Carter; J J LiPuma; T L Stull
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

6.  Microbiological and epidemiological features of clinical respiratory isolates of Burkholderia gladioli.

Authors:  Christine Segonds; Patricia Clavel-Batut; Michelle Thouverez; Dominique Grenet; Alain Le Coustumier; Patrick Plésiat; Gérard Chabanon
Journal:  J Clin Microbiol       Date:  2009-03-18       Impact factor: 5.948

7.  Discrimination of Burkholderia gladioli from other Burkholderia species detectable in cystic fibrosis patients by PCR.

Authors:  A Bauernfeind; I Schneider; R Jungwirth; C Roller
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

8.  Two cases of keratitis and corneal ulcers caused by Burkholderia gladioli.

Authors:  Franka Lestin; Robert Kraak; Andreas Podbielski
Journal:  J Clin Microbiol       Date:  2008-04-23       Impact factor: 5.948

9.  Clinical outcome after acquisition of Burkholderia cepacia in patients with cystic fibrosis.

Authors:  M McCloskey; J McCaughan; A O Redmond; J S Elborn
Journal:  Ir J Med Sci       Date:  2001 Jan-Mar       Impact factor: 2.089

Review 10.  An Overview of Metabolic Activity, Beneficial and Pathogenic Aspects of Burkholderia Spp.

Authors:  Hazem S Elshafie; Ippolito Camele
Journal:  Metabolites       Date:  2021-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.